Oroschakoff Michelle 4
4 · LPL Financial Holdings Inc. · Filed Nov 21, 2022
Insider Transaction Report
Form 4
Oroschakoff Michelle
MD, Chief Risk Officer
Transactions
- Sale
Common Stock
2022-11-17$213.80/sh−5,213$1,114,539→ 41,100.148 total - Exercise/Conversion
Common Stock
2022-11-17$77.53/sh+7,680$595,430→ 46,313.148 total - Exercise/Conversion
Option to purchase Common Stock
2022-11-17−7,680→ 0 totalExercise: $77.53Exp: 2029-02-25→ Common Stock (7,680 underlying)
Footnotes (4)
- [F1]The stock option exercise reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on June 14, 2022.
- [F2]The sale reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on June 14, 2022.
- [F3]Consists of (i) 36,571.15 shares of Common Stock; (ii) 1,019 restricted stock units that vest in full on February 25, 2023; (iii) 1,693 restricted stock units that vest ratably on each of February 25, 2023 and February 25, 2024; and (iv) 1,817 restricted stock units that vest ratably on each of February 25, 2023, February 25, 2024 and February 25, 2025.
- [F4]This option became exercisable in three installments, beginning on February 25, 2020, which was the first anniversary of the date on which it was granted. The option became fully vested on February 25, 2022.